Dropdown

EE - Estonia
All companies
    All persons

      Search word:

      Field/EMTAK

      PADAKONN PHARMA OÜ

      Media page and news feed
      ?
      ?
      profile visits
      478
      ?
      company tracker
      1
      This company's branding has already reached 478 peopleand his is followed by 1 Storybook user.On average, the company has been rated 2.8 points.but there is no

      PADAKONN PHARMA OÜ current status

      2184939_andmerobot_99391772_a_xl.jpg
      Andmerobot
      Did you notice typos in the article?

      Dropdown

      This company's branding has already reached 478 peopleand his is followed by 1 Storybook user.On average, the company has been rated 2.8 points.but there is no comment.

      Tegevusaruanne 2023

      Firma Padakonn Pharma OÜ oli registreeritud 2020 aasta veebruari kuus.

      Padakonn Pharma OÜ põhitegevuseks 2023 aastal oli teimimine ja analüüs (71209 EMTAK).

      2023 aastal moodustas Padakonn Pharma OÜ müügitulu 254 000 eurot. 2023 aastal kasum oli summas 177 123 eurot.

      2023 aasta jooksul erisoodustust juhatuse liikmele ei maksnud. 2023 aastal Haakoh OÜ töötas 1 (uks) inimest. 2023 aastal tööjõukulud oli 36 409 eurot koos sotsiaalmaksuga ja töötuskindlustusega.

      Comments (0)

      Are you sure you want to delete this article?

      Dropdown

      all articles

      File a complaint

      Choose the comment attribute that you think it contains:

      False information
      Spam
      Hate speech
      Terrorism
      Other

      You want to report an inappropriate comment.

      Are you sure?

      Are you sure you want to delete this article?

      Loader

      Loader

      App Ad

      Scorestorybook Chrome extension

      The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

      See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.

      We value your privacy

      We use cookies to improve your browsing experience, provide personalized ads or content, and analyze our traffic. By clicking "allow all", you agree to our use of all cookies.